THANK YOU FOR SUBSCRIBING
A comprehensive research effort is being conducted to find limitations to safe use. Using bionic technologies, insulin can be delivered precisely and automated, reducing patient burden and improving glucose control
Fremont, CA: Diabetes management has evolved with the introduction of insulin pens, pumps, CGM devices, and Artificial Pancreas Systems, improving glucose control, accessibility, and decision-making, enhancing diabetics' quality of life and underscoring the critical role of medical devices in diabetes care.
A Look at Insulin's Evolution
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
As insulin delivery methods have evolved, they've usually caused inconsistent blood glucose control because they required manual injections. In the early days, pumps offered continuous subcutaneous infusion, but they were bulky, required frequent site changes, and had a hard time being discreet, socially stigmatized, and doing complex calculations.
The Age of Bionic Technology
A bionic device mimics biological processes in the medical field, making patients' lives better and healthier. It combines biological and artificial elements to enhance human body functions. As an example, bionic insulin delivery systems like APS monitor glucose levels, send insulin and use sensors like pancreatic function to manage diabetes.
Artificial Pancreas and Next-Generation Insulin Pumps
In modern insulin pumps, CGMs, predictive low glucose suspend capabilities, and Smartphone connectivity makes them more accurate, adaptable, and user-friendly. Using real-time CGM data, they reduce hypoglycemia and hyperglycemia risks by adjusting insulin delivery. The artificial pancreas monitors glucose levels and administers precise doses, just like the pancreas does in nature.
Benefits and Improvements for Patients
Advanced insulin pumps and artificial pancreas systems offer convenience, efficiency, and safety for people with diabetes. They automate insulin delivery, reduce injections, and allow users to fine-tune insulin profiles. With these devices, glucose levels are continuously monitored, and doses are precisely delivered for better glycemic control, reducing hypoglycemia risk and improving overall health.
Challenges and Considerations
Advanced diabetes management devices face challenges like affordability, maintenance, and training. Medical professionals are studying long-term implications like durability and performance, as well as potential infections. A comprehensive research effort is being conducted to find limitations to safe use. Using bionic technologies, insulin can be delivered precisely and automated, reducing patient burden and improving glucose control. It's crucial to keep researching and innovating to improve patient care.
More in News